Armata Pharmaceuticals, Inc.

DB:TG1N Stock Report

Market Cap: €67.1m

Armata Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TG1N?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders71,0780.196%
Institutions1,391,1283.84%
General Public9,644,09226.7%
Public Companies25,076,76969.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
69.3%
Innoviva, Inc.
25,076,769€46.5m0%no data
1.75%
Bank of America Corporation, Asset Management Arm
634,032€1.2m0%no data
0.65%
The Vanguard Group, Inc.
234,119€434.1k3.92%no data
0.3%
Geode Capital Management, LLC
106,789€198.0k-0.26%no data
0.28%
Edgewood Management LLC
100,000€185.4k0%no data
0.19%
Bridgeway Capital Management, LLC
69,682€129.2k-7.56%no data
0.17%
Mina Pastagia
61,078€113.3k0%no data
0.14%
Susquehanna International Group, LLP, Asset Management Arm
49,788€92.3k67.2%no data
0.11%
State Street Global Advisors, Inc.
40,300€74.7k0%no data
0.11%
Renaissance Technologies LLC
40,291€74.7k-13.4%no data
0.097%
SeaCrest Wealth Management, LLC
34,954€64.8k0%0.01%
0.065%
BlackRock, Inc.
23,625€43.8k-0.75%no data
0.053%
Northern Trust Global Investments
19,273€35.7k0%no data
0.036%
CapFinancial Partners, LLC, Asset Management Arm
13,140€24.4k0%no data
0.032%
Group One Trading LP, Asset Management Arm
11,614€21.5k-42.8%no data
0.028%
Pierre Kyme
10,000€18.5k0%no data
0.017%
UBS Asset Management AG
6,313€11.7k168%no data
0.0092%
Tower Research Capital Europe Limited
3,312€6.1k65.2%no data
0.0064%
Lord, Abbett & Co. LLC
2,302€4.3k0%no data
0.002%
Trifecta Capital Advisors, LLC
714€1.3k0%no data
0.0016%
Northwestern Mutual Wealth Management Company
571€1.1k0%no data
0.0003%
Morgan Stanley, Investment Banking and Brokerage Investments
109€201.30%no data
0.00028%
Salem Investment Counselors, Inc.
100€187.90%no data
0.0002%
MAI Capital Management, LLC
71€134.20%no data
0.00007%
JPMorgan Chase & Co, Brokerage and Securities Investments
25€47.0-3.85%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 04:36
End of Day Share Price 2025/02/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Armata Pharmaceuticals, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph PantginisH.C. Wainwright & Co.